Compare VALN & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | ASLE |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 875.7M | 296.8M |
| IPO Year | 2021 | 2018 |
| Metric | VALN | ASLE |
|---|---|---|
| Price | $6.26 | $6.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $15.75 | $7.00 |
| AVG Volume (30 Days) | 82.6K | ★ 290.8K |
| Earning Date | 03-18-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.64 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $335,286,000.00 |
| Revenue This Year | $4.00 | $23.41 |
| Revenue Next Year | $92.04 | $6.80 |
| P/E Ratio | ★ N/A | $34.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.43 | $5.56 |
| 52 Week High | $12.25 | $9.08 |
| Indicator | VALN | ASLE |
|---|---|---|
| Relative Strength Index (RSI) | 25.09 | 30.61 |
| Support Level | $5.69 | $6.05 |
| Resistance Level | $6.73 | $6.17 |
| Average True Range (ATR) | 0.42 | 0.15 |
| MACD | -0.57 | -0.00 |
| Stochastic Oscillator | 0.00 | 12.35 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.